메뉴 건너뛰기




Volumn 56, Issue 1, 2010, Pages 71-81

Carnitine deficiency aggravates cyclophosphamide-induced cardiotoxicity in rats

Author keywords

Cardiomyopathy; Carnitine deficiency; Cyclophosphamide; D Carnitine; Mildronate; Propionyl L carnitine

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CARNITINE; CREATINE KINASE; CYCLOPHOSPHAMIDE; LACTATE DEHYDROGENASE; MILDRONATE; PROPIONYLCARNITINE;

EID: 77950532161     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000298822     Document Type: Article
Times cited : (22)

References (61)
  • 1
    • 0035950826 scopus 로고    scopus 로고
    • Cyclophosphamide and related anticancer drugs
    • Baumann F, Preiss R: Cyclophosphamide and related anticancer drugs. J Chromatogr B Biomed Sci Appl 2001; 764: 173-192.
    • (2001) J Chromatogr B Biomed Sci Appl , vol.764 , pp. 173-192
    • Baumann, F.1    Preiss, R.2
  • 2
    • 0022905604 scopus 로고
    • Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine
    • Murphy SB, Bowman WP, Abromowitch M, Mirro J, Ochs J, Rivera G, Pui CH, Berard FD: Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986; 4: 1732-1739.
    • (1986) J Clin Oncol , vol.4 , pp. 1732-1739
    • Murphy, S.B.1    Bowman, W.P.2    Abromowitch, M.3    Mirro, J.4    Ochs, J.5    Rivera, G.6    Pui, C.H.7    Berard, F.D.8
  • 3
    • 49549102195 scopus 로고    scopus 로고
    • High-dose chemotherapy without stem cell transplantation for refractory childhood systemic lupus erythematosus
    • Luo XO, Mo Y, Ke ZY, Xu L, Jiang XY, Zhang TT, Chen SM: High-dose chemotherapy without stem cell transplantation for refractory childhood systemic lupus erythematosus. Chemotherapy 2008; 54: 331-335.
    • (2008) Chemotherapy , vol.54 , pp. 331-335
    • Luo, X.O.1    Mo, Y.2    Ke, Z.Y.3    Xu, L.4    Jiang, X.Y.5    Zhang, T.T.6    Chen, S.M.7
  • 4
    • 0020406634 scopus 로고
    • Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)
    • Brock N, Stekar PJ, Scheef W: Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna). Eur J Cancer Clin Oncol 1982; 18: 1377-1387.
    • (1982) Eur J Cancer Clin Oncol , vol.18 , pp. 1377-1387
    • Brock, N.1    Stekar, P.J.2    Scheef, W.3
  • 5
    • 0032826199 scopus 로고    scopus 로고
    • An overview of cyclophosphamide development and clinical applications
    • Colvin OM: An overview of cyclophosphamide development and clinical applications. Curr Pharm Des 1999; 5: 555-560.
    • (1999) Curr Pharm des , vol.5 , pp. 555-560
    • Colvin, O.M.1
  • 6
    • 0032849465 scopus 로고    scopus 로고
    • The chemistry of the metabolites of cyclophosphamide
    • Ludeman SM: The chemistry of the metabolites of cyclophosphamide. Curr Pharm Des 1999; 5: 627-634.
    • (1999) Curr Pharm des , vol.5 , pp. 627-634
    • Ludeman, S.M.1
  • 7
    • 0034888045 scopus 로고    scopus 로고
    • Acute life-threatening toxicity of cancer treatment
    • Shanholtz C: Acute life-threatening toxicity of cancer treatment. Crit Care Clin 2001; 17: 483-502.
    • (2001) Crit Care Clin , vol.17 , pp. 483-502
    • Shanholtz, C.1
  • 8
    • 0018646130 scopus 로고
    • Cyclophosphamideinduced cardiomyopathy: A report of two cases and review of the English literature
    • Mills BA, Roberts RW: Cyclophosphamideinduced cardiomyopathy: a report of two cases and review of the English literature. Cancer 1979; 4: 2223-2226.
    • (1979) Cancer , vol.4 , pp. 2223-2226
    • Mills, B.A.1    Roberts, R.W.2
  • 11
    • 0022806838 scopus 로고
    • Cyclophosphamide cardiotoxicity: An analysis of dosing as a risk factor
    • Goldberg MA, Antin JH, Guinan EC, Rappeport JM: Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood 1986; 68: 1114-1118.
    • (1986) Blood , vol.68 , pp. 1114-1118
    • Goldberg, M.A.1    Antin, J.H.2    Guinan, E.C.3    Rappeport, J.M.4
  • 12
    • 10644259704 scopus 로고    scopus 로고
    • Protective effect of DL-α-lipoic acid on cyclophosphamide induced oxidative cardiac injury
    • DOI 10.1016/j.cbi.2004.10.004, PII S0009279704001772
    • Mythili Y, Sudharsan PT, Selvakumar E, Varalakshmi P: Protective effect of DL- lipoic acid on cyclophosphamide induced oxidative cardiac injury. Chem Biol Interact 2004; 151: 13-19. (Pubitemid 39647933)
    • (2004) Chemico-Biological Interactions , vol.151 , Issue.1 , pp. 13-19
    • Mythili, Y.1    Sudharsan, P.T.2    Selvakumar, E.3    Varalakshmi, P.4
  • 13
    • 0024834475 scopus 로고
    • Alterations of serum and urinary carnitine profiles in cancer patients: Hypothesis of possible significance
    • Dodson WL, Sachan DS, Krauss S, Hanna W: Alterations of serum and urinary carnitine profiles in cancer patients: hypothesis of possible significance. J Am Coll Nutr 1989; 8: 133-142.
    • (1989) J Am Coll Nutr , vol.8 , pp. 133-142
    • Dodson, W.L.1    Sachan, D.S.2    Krauss, S.3    Hanna, W.4
  • 14
    • 33845349279 scopus 로고    scopus 로고
    • Safety, tolerability and symptom outcomes associated with L -carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: A phase I/II study
    • Cruciani RA, Dvorkin E, Homel P, Malamud S, Culliney B, Lapin J, Portenoy RK, Esteban- Cruciani N: Safety, tolerability and symptom outcomes associated with L -carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study. J Pain Symptom Manage 2006; 32: 551-559.
    • (2006) J Pain Symptom Manage , vol.32 , pp. 551-559
    • Cruciani, R.A.1    Dvorkin, E.2    Homel, P.3    Malamud, S.4    Culliney, B.5    Lapin, J.6    Portenoy, R.K.7    Esteban- Cruciani, N.8
  • 15
    • 0033978634 scopus 로고    scopus 로고
    • Cancer and anticancer therapy-induced modifications on metabolism meditated by carnitine system
    • Peluso G, Nicolai R, Reda E, Bennati P, Barbarisi P, Calvani M: Cancer and anticancer therapy-induced modifications on metabolism meditated by carnitine system. J Cell Physiol 2002; 182: 339-350.
    • (2002) J Cell Physiol , vol.182 , pp. 339-350
    • Peluso, G.1    Nicolai, R.2    Reda, E.3    Bennati, P.4    Barbarisi, P.5    Calvani, M.6
  • 16
    • 0032925677 scopus 로고    scopus 로고
    • Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats
    • Visarius TM, Stucki JW, Lauterburg BH: Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats. J Pharmacol Exp Ther 1999; 289: 820-824.
    • (1999) J Pharmacol Exp Ther , vol.289 , pp. 820-824
    • Visarius, T.M.1    Stucki, J.W.2    Lauterburg, B.H.3
  • 17
    • 0019796279 scopus 로고
    • Tissue specific depletion of L -carnitine in rat heart and skeletal muscle by D -carnitine
    • Paulson DJ, Shug AL: Tissue specific depletion of L -carnitine in rat heart and skeletal muscle by D -carnitine. Life Sci 1981; 28: 2931-2938.
    • (1981) Life Sci , vol.28 , pp. 2931-2938
    • Paulson, D.J.1    Shug, A.L.2
  • 18
    • 0023232325 scopus 로고
    • L -Carnitine treatment improves cardiac performance and restores high energy phosphate pools in cardiomyopathic Syrian hamster
    • Whitmer JT: L -Carnitine treatment improves cardiac performance and restores high energy phosphate pools in cardiomyopathic Syrian hamster. Circ Res 1987; 61: 396-408.
    • (1987) Circ Res , vol.61 , pp. 396-408
    • Whitmer, J.T.1
  • 19
    • 0029001125 scopus 로고
    • Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of L -carnitine by D -carnitine and a -butyrobetaine hydroxylase inhibitor
    • Tsoko M, Beauseigneur F, Gresti J, Niot I, Demarquoy J, Boichot J, Bezard J, Rochette L, Clouet P: Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of L -carnitine by D -carnitine and a -butyrobetaine hydroxylase inhibitor. Biochem Pharmacol 1995; 49: 1403-1410.
    • (1995) Biochem Pharmacol , vol.49 , pp. 1403-1410
    • Tsoko, M.1    Beauseigneur, F.2    Gresti, J.3    Niot, I.4    Demarquoy, J.5    Boichot, J.6    Bezard, J.7    Rochette, L.8    Clouet, P.9
  • 20
    • 0032940435 scopus 로고    scopus 로고
    • Pharmacokinetic analysis of the cardioprotective effect of 3-( 2, 2, 2-trimethylhydrazinium) propionate in mice: Inhibition of carnitine transport in kidney
    • Kuwajima M, Harashima H, Hayashi M, Ise S, Sei M, Lu K, Kiwada H, Sugiyama Y, Shima K: Pharmacokinetic analysis of the cardioprotective effect of 3-(2,2, 2-trimethylhydrazinium) propionate in mice: inhibition of carnitine transport in kidney. J Pharmacol Exp Ther 1999; 289: 93-102.
    • (1999) J Pharmacol Exp Ther , vol.289 , pp. 93-102
    • Kuwajima, M.1    Harashima, H.2    Hayashi, M.3    Ise, S.4    Sei, M.5    Lu, K.6    Kiwada, H.7    Sugiyama, Y.8    Shima, K.9
  • 23
    • 0017816152 scopus 로고
    • Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate- to-lactate reactions in human serum at 25, 30, and 37 degrees C
    • Buhl SN, Jackson KY: Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate- to-lactate reactions in human serum at 25, 30, and 37 degrees C. Clin Chem 1978; 24: 828-831.
    • (1978) Clin Chem , vol.24 , pp. 828-831
    • Buhl, S.N.1    Jackson, K.Y.2
  • 24
    • 0019958463 scopus 로고
    • Evaluation and comparison of immunoinhibition and immunoprecipitation methods for differentiating MB and BB from macro forms of creatine kinase isoenzymes in patients and healthy individuals
    • Wu AH, Bowers GN Jr: Evaluation and comparison of immunoinhibition and immunoprecipitation methods for differentiating MB and BB from macro forms of creatine kinase isoenzymes in patients and healthy individuals. Clin Chem 1982; 28: 2017-2021.
    • (1982) Clin Chem , vol.28 , pp. 2017-2021
    • Wu, A.H.1    Bowers Jr., G.N.2
  • 25
    • 33748978227 scopus 로고    scopus 로고
    • Determination of free and total carnitine in plasma by an enzymatic reaction and spectrophotometric quantitation spectrophotometric determination of carnitine
    • Prieto JA, Andrade F, Aldámiz-Echevarría L, Sanjurjo P: Determination of free and total carnitine in plasma by an enzymatic reaction and spectrophotometric quantitation spectrophotometric determination of carnitine. Clin Biochem 2006; 39: 1022-1027.
    • (2006) Clin Biochem , vol.39 , pp. 1022-1027
    • Prieto, J.A.1    Andrade, F.2    Aldámiz-Echevarría, L.3    Sanjurjo, P.4
  • 26
    • 0003024032 scopus 로고
    • Preparation of mitochrondria from animal tissues and yeasts
    • Birnie GD (ed): ed 2. London Butterworths
    • Chappell JB, Hansford RG: Preparation of mitochrondria from animal tissues and yeasts; in Birnie GD (ed): Subcellular Components: Preparation and Fractionation. ed 2. London, Butterworths, 1969, pp 77-91.
    • (1969) Subcellular Components: Preparation and Fractionation , pp. 77-91
    • Chappell, J.B.1    Hansford, R.G.2
  • 27
    • 0017184389 scopus 로고
    • A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding
    • Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976; 72: 248-254.
    • (1976) Anal Biochem , vol.72 , pp. 248-254
    • Bradford, M.M.1
  • 28
    • 0023856860 scopus 로고
    • Quantitation of the effect of L -carnitine on the levels of acid-soluble short-chain acyl- CoA and CoASH in rat heart and liver mitochondria
    • Lysiak W, Lilly K, DiLisa F, Toth PP, Bieber LL: Quantitation of the effect of L -carnitine on the levels of acid-soluble short-chain acyl- CoA and CoASH in rat heart and liver mitochondria. J Biol Chem 1988; 263: 1151-1156.
    • (1988) J Biol Chem , vol.263 , pp. 1151-1156
    • Lysiak, W.1    Lilly, K.2    Dilisa, F.3    Toth, P.P.4    Bieber, L.L.5
  • 29
    • 0028346882 scopus 로고
    • Analytical evaluation of high energy phosphate determination by high performance liquid chromatography in myocardial tissue
    • Botker HE, Kimose HH, Helligso P, Nielsen TT: Analytical evaluation of high energy phosphate determination by high performance liquid chromatography in myocardial tissue. J Mol Cell Cardiol 1994; 26: 41-48.
    • (1994) J Mol Cell Cardiol , vol.26 , pp. 41-48
    • Botker, H.E.1    Kimose, H.H.2    Helligso, P.3    Nielsen, T.T.4
  • 30
    • 3042934967 scopus 로고
    • Tissue sulfhydryl groups
    • Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
    • (1959) Arch Biochem Biophys , vol.82 , pp. 70-77
    • Ellman, G.L.1
  • 31
    • 0018384650 scopus 로고
    • Assay for lipid peroxides in animal tissues by thiobarbituric acid
    • Ohkawa H, Ohish N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid. Anal Biochem 1979; 95: 351-358.
    • (1979) Anal Biochem , vol.95 , pp. 351-358
    • Ohkawa, H.1    Ohish, N.2    Yagi, K.3
  • 33
    • 67349280855 scopus 로고    scopus 로고
    • Oral glutamine protects against cyclophosphamide- induced cardiotoxicity in experimental rats through increase of cardiac glutathione
    • Todorova V, Vanderpool D, Blossom S, Nwokedi E, Hennings L, Mrak R, Klimberg VS: Oral glutamine protects against cyclophosphamide- induced cardiotoxicity in experimental rats through increase of cardiac glutathione. Nutrition 2009; 25: 812-817.
    • (2009) Nutrition , vol.25 , pp. 812-817
    • Todorova, V.1    Vanderpool, D.2    Blossom, S.3    Nwokedi, E.4    Hennings, L.5    Mrak, R.6    Klimberg, V.S.7
  • 34
    • 0025323320 scopus 로고
    • Leakage of cytoplasmic enzymes from rat heart by the stress of cardiac beating after increase in cell membrane fragility by anoxia
    • Takami H, Matsuda H, Kuki S, Nishimura M, Kawashima Y, Watari H, Furuya E, Tagawa K: Leakage of cytoplasmic enzymes from rat heart by the stress of cardiac beating after increase in cell membrane fragility by anoxia. Pflugers Arch 1990; 416: 1-2.
    • (1990) Pflugers Arch , vol.416 , pp. 1-2
    • Takami, H.1    Matsuda, H.2    Kuki, S.3    Nishimura, M.4    Kawashima, Y.5    Watari, H.6    Furuya, E.7    Tagawa, K.8
  • 36
    • 58149471362 scopus 로고    scopus 로고
    • Neutrophil infiltration and oxidative stress may play a critical role in methotrexate- induced renal damage
    • Kolli WK, Abraham P, Isaac B, Selvakumar D: Neutrophil infiltration and oxidative stress may play a critical role in methotrexate- induced renal damage. Chemotherapy 2009; 55: 83-90.
    • (2009) Chemotherapy , vol.55 , pp. 83-90
    • Kolli, W.K.1    Abraham, P.2    Isaac, B.3    Selvakumar, D.4
  • 37
    • 54949101658 scopus 로고    scopus 로고
    • Protective effect of geranylgeranylacetone on cisplatin ototoxicity
    • Yin HY, Ma XF, Liu F, Xia M, Xu AT: Protective effect of geranylgeranylacetone on cisplatin ototoxicity. Chemotherapy 2009; 55: 1-5.
    • (2009) Chemotherapy , vol.55 , pp. 1-5
    • Yin, H.Y.1    Ma, X.F.2    Liu, F.3    Xia, M.4    Xu, A.T.5
  • 39
    • 0027453676 scopus 로고
    • Sites of action of carnitine and its derivatives on the cardiovascular system: Interactions with membranes
    • Fritz IB, Arrigoni-Martelli E: Sites of action of carnitine and its derivatives on the cardiovascular system: interactions with membranes. Trends Pharmacol Sci 1993; 14: 355-360.
    • (1993) Trends Pharmacol Sci , vol.14 , pp. 355-360
    • Fritz, I.B.1    Arrigoni-Martelli, E.2
  • 43
    • 0027459172 scopus 로고
    • Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy
    • DOI 10.1002/mus.880160205
    • Campos Y, Huertas R, Lorenzo G, Bautista J, Gutierrez E, Aparicio M, Alesso L, Arenas J: Plasma carnitine insufficiency and effectiveness of L -carnitine therapy in patients with mitochondrial myopathy. Muscle Nerve 1993; 16: 150-153. (Pubitemid 23030999)
    • (1993) Muscle and Nerve , vol.16 , Issue.2 , pp. 150-153
    • Campos, Y.1    Huertas, R.2    Lorenzo, G.3    Bautista, J.4    Gutierrez, E.5    Aparicio, M.6    Alesso, L.7    Arenas, J.8
  • 46
    • 33750734282 scopus 로고    scopus 로고
    • Lupeol and its ester inhibit alteration of myocardial permeability in cyclophosphamide administered rats
    • Sudharsan PT, Mythili Y, Selvakumar E, Varalakshmi P: Lupeol and its ester inhibit alteration of myocardial permeability in cyclophosphamide administered rats. Mol Cell Biochem 2006; 292: 39-44.
    • (2006) Mol Cell Biochem , vol.292 , pp. 39-44
    • Sudharsan, P.T.1    Mythili, Y.2    Selvakumar, E.3    Varalakshmi, P.4
  • 49
    • 56049117823 scopus 로고    scopus 로고
    • Carnitine deficiency aggravates carboplatin nephropathy through deterioration of energy status, oxidant/anti-oxidant balance, and inflammatory endocoids
    • Arafa HM: Carnitine deficiency aggravates carboplatin nephropathy through deterioration of energy status, oxidant/anti-oxidant balance, and inflammatory endocoids. Toxicology 2008; 254: 51-60.
    • (2008) Toxicology , vol.254 , pp. 51-60
    • Arafa, H.M.1
  • 51
    • 0033729907 scopus 로고    scopus 로고
    • Pharmacokinetics of propionyl- L -carnitine in humans: Evidence for saturable tubular reabsorption
    • Pace S, Longo A, Toon S, Rolan P, Evans AM: Pharmacokinetics of propionyl- L -carnitine in humans: evidence for saturable tubular reabsorption. Br J Clin Pharmacol 2000; 50: 441-448.
    • (2000) Br J Clin Pharmacol , vol.50 , pp. 441-448
    • Pace, S.1    Longo, A.2    Toon, S.3    Rolan, P.4    Evans, A.M.5
  • 52
    • 0028982336 scopus 로고
    • Disposition of L -carnitine and acetyl- L - Carnitine in the isolated perfused rat kidney
    • Mancinelli A, Longo A, Shanahan K, Evans AM: Disposition of L -carnitine and acetyl- L - carnitine in the isolated perfused rat kidney. J Pharmacol Exp Ther 1995; 274: 1122-1128.
    • (1995) J Pharmacol Exp Ther , vol.274 , pp. 1122-1128
    • Mancinelli, A.1    Longo, A.2    Shanahan, K.3    Evans, A.M.4
  • 53
    • 0030925428 scopus 로고    scopus 로고
    • Excretion and metabolism of propionyl- L -carnitine in the isolated perfused rat kidney
    • Evans AM, Mancinelli A, Longo A: Excretion and metabolism of propionyl- L -carnitine in the isolated perfused rat kidney. J Pharmacol Exp Ther 1997; 281: 1071-1076.
    • (1997) J Pharmacol Exp Ther , vol.281 , pp. 1071-1076
    • Evans, A.M.1    Mancinelli, A.2    Longo, A.3
  • 54
    • 0034911794 scopus 로고    scopus 로고
    • Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide
    • Dubourg L, Michoudet C, Cochat P, Baverel G: Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide. J Am Soc Nephrol 2001; 12: 1615-1623.
    • (2001) J Am Soc Nephrol , vol.12 , pp. 1615-1623
    • Dubourg, L.1    Michoudet, C.2    Cochat, P.3    Baverel, G.4
  • 55
    • 1842389677 scopus 로고
    • Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle
    • Neely JR, Morgan HE: Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 1974; 36: 413-459.
    • (1974) Annu Rev Physiol , vol.36 , pp. 413-459
    • Neely, J.R.1    Morgan, H.E.2
  • 56
    • 0344074048 scopus 로고    scopus 로고
    • Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in rats
    • Visarius TM, Bähler H, Küpfer A, Cerny T, Lauterburg BH.: Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in rats. Drug Metab Dispos 1998; 26: 193-196.
    • (1998) Drug Metab Dispos , vol.26 , pp. 193-196
    • Visarius, T.M.1    Bähler, H.2    Küpfer, A.3    Cerny, T.4    Lauterburg, B.H.5
  • 57
    • 0032925677 scopus 로고    scopus 로고
    • Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats
    • Visarius TM, Stucki JW, Lauterburg BH: Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats. J Pharmacol Exp Ther 1999; 289: 820-824.
    • (1999) J Pharmacol Exp Ther , vol.289 , pp. 820-824
    • Visarius, T.M.1    Stucki, J.W.2    Lauterburg, B.H.3
  • 58
    • 85047675973 scopus 로고
    • Protection of the ischaemic myocardium by L -propionylcarnitine: Effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation
    • Paulson DJ, Traxler J, Schmidt M, Noonan J, Shug AL: Protection of the ischaemic myocardium by L -propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation. Cardiovasc Res 1986; 20: 536-541.
    • (1986) Cardiovasc Res , vol.20 , pp. 536-541
    • Paulson, D.J.1    Traxler, J.2    Schmidt, M.3    Noonan, J.4    Shug, A.L.5
  • 59
    • 10644296223 scopus 로고    scopus 로고
    • Therapeutic effects of L -carnitine and propionyl- L -carnitine on cardiovascular diseases: A review
    • Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C: Therapeutic effects of L -carnitine and propionyl- L -carnitine on cardiovascular diseases: a review. Ann NY Acad Sci 2004; 1033: 79-91.
    • (2004) Ann NY Acad Sci , vol.1033 , pp. 79-91
    • Ferrari, R.1    Merli, E.2    Cicchitelli, G.3    Mele, D.4    Fucili, A.5    Ceconi, C.6
  • 61
    • 0036715482 scopus 로고    scopus 로고
    • L -Carnitine inhibits cisplatin-induced injury of the kidney and small intestine
    • Chang B, Nishikawa M, Sato E, Utsumi K, Inoue M: L -Carnitine inhibits cisplatin-induced injury of the kidney and small intestine. Arch Biochem Biophys 2002; 405: 55-64.
    • (2002) Arch Biochem Biophys , vol.405 , pp. 55-64
    • Chang, B.1    Nishikawa, M.2    Sato, E.3    Utsumi, K.4    Inoue, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.